42.32USD+13.79%Mkt Cap: 1.16B $P/E: —1d ago
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-…
Industry Peers
Drug Manufacturers - Specialty & Generic$64.41BUSDP/E 23.3
$22.74BUSDP/E 19.8
$20.14BUSD
$17.18BUSDP/E 26.3
$15.40BUSDP/E 118.1
$14.51BUSDP/E 30.3
$12.90BUSD
$9.04BUSDP/E 23.0
$7.60BUSD
$7.11BUSDP/E 470.2
$7.00BUSDP/E 25.7
$5.70BUSDP/E 48.2
$3.69BUSDP/E 19.2
$3.57BUSDP/E 11.4
$3.01BUSDP/E 21.0
$2.79BUSD
$2.53BUSDP/E 56.2
$2.33BUSDP/E 16.1
$2.36BUSDP/E 12.8
$2.36BUSD
$1.90BUSDP/E 19.2
$1.97BUSD
$1.80BUSDP/E 20.3
$1.84BUSD
$1.74BUSD
$1.57BUSD
$1.48BUSDP/E 17.5
$1.52BUSDP/E 125.7
$1.35BUSDP/E 14.3
$1.21BUSDP/E 38.0
$1.17BUSDP/E 17.5
$1.20BUSD
$1.07BUSDP/E Infinity
$1.01BUSD
$1.01BUSDP/E 197.0
$902.17MUSDP/E 14.5
$883.62MUSDP/E 38.6
$870.61MUSDP/E 11.9
$819.46MUSDP/E Infinity
$664.05MUSD
$702.13MUSDP/E 163.7
$635.41MUSDP/E 6.2
$503.88MUSDP/E 14.2
$516.92MUSD
$463.93MUSD
$437.60MUSD
$393.68MUSD
$377.35MUSD
$359.47MUSD
$339.22MUSD
$337.13MUSD
$319.75MUSDP/E 43.6
$351.79MUSD
$303.26MUSDP/E 9.7
$290.59MUSD
$267.31MUSDP/E 48.0
$280.94MUSDP/E 14.5
$250.29MUSDP/E 47.6
$246.73MUSDP/E 12.3
$233.72MUSDP/E 52.4
$207.94MUSDP/E 10.3
$202.91MUSD
$197.15MUSD
$187.92MUSDP/E 9.0
$175.54MUSD
$166.91MUSD
$143.51MUSDP/E 18.3
$132.34MUSD
$141.87MUSD
$128.15MUSD
$119.66MUSDP/E 18.6
$102.48MUSD
$85.39MUSDP/E 12.3
$93.61MUSD
$72.08MUSD
$65.22MUSD
$68.77MUSD
$63.45MUSDP/E 29.2
$60.45MUSDP/E 51.0
$64.05MUSD
$53.24MUSD
$52.01MUSD
$51.08MUSD
$49.45MUSD
$41.74MUSD
$46.21MUSD
$33.86MUSDP/E Infinity
$37.20MUSD
$31.62MUSD
$27.40MUSD
$24.18MUSD
$23.84MUSDP/E 206.0
$23.98MUSD
$23.08MUSD
$22.15MUSD
$18.78MUSD
$18.30MUSD
$14.93MUSD
$13.64MUSDP/E 16.6
$13.96MUSD
$11.82MUSD
$11.45MUSD
$9.96MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.51MUSDP/E 4.0
$6.35MUSD
$5.98MUSDP/E 0.2
$5.79MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$1.93MUSD
$1.85MUSD
$1.85MUSDP/E 31.6
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap1.16B $
Enterprise Value1.07B $
Revenue (TTM)86.93M $
Gross Profit42.74M $
Net Income (TTM)-4.60M $
Revenue/Share3.219 USD
Last Price42.32 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees44
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)19.78
PEG—
EV/EBITDA96.19
EV/Revenue12.26
P/S11.72
P/B33.24
EPS (TTM)-0.06
EPS (Forward)1.88
52W Range
13.7699% of range42.65
52W High42.65 USD
52W Low13.76 USD
Profitability
Gross Margin53.46%
Oper. Margin11.39%
EBITDA Margin12.75%
Profit Margin-5.75%
ROE-17.59%
ROA-4.99%
Growth
Revenue Growth40.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF10.52M $
CapEx (TTM)333.00K $
FCF Margin2.81%
FCF Yield0.21%
Net Debt11.60M $
Net Debt/EBITDA1.05
Balance Sheet
Debt/Equity1.19
Current Ratio1.21
Quick Ratio0.75
Book Value/Sh1.119 USD
Cash/Share0.7180 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)45.67 USD
Upside (mean)+7.9%
Target Range40.00 USD – 57.00 USD
$40.00+7.9% to mean$57.00
# Analysts3
Ownership
Shares Out.27.39M
Float21.25M
Insiders5.32%
Institutions66.08%
Short Interest
Short Ratio3.5d
Short % Float7.44%
Short % Out.5.29%
Shares Short1.45M
Short (prev mo.)1.26M
Technical
SMA 5032.78 (+29.1%)
SMA 20022.25 (+90.2%)
Beta0.86
S&P 52W Chg20.25%
Avg Vol (30d)403.62K
Avg Vol (10d)408.82K
Technical Indicators
RSI (14)75.5
MACD2.0247
MACD Signal1.8111
MACD Hist.+0.2137
BB Upper41.05 USD
BB Middle36.28 USD
BB Lower31.51 USD
BB Width26.30%
ATR (14)2.013 USD
Vol Ratio (20d)3.02x